mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.02 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |